Skip to main content
Erschienen in: European Journal of Pediatrics 6/2019

04.03.2019 | Original Article

Outcomes following venoarterial extracorporeal membrane oxygenation in children with refractory cardiogenic disease

verfasst von: Lijun Yang, Lifen Ye, Yong Fan, Wenlong He, Qing Zong, Wenting Zhao, Ru Lin

Erschienen in: European Journal of Pediatrics | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Retrospective analysis was performed at an affiliated university children’s hospital with consecutive patients receiving a venoarterial extracorporeal membrane oxygenation (VA-ECMO) for refractory cardiogenic shock from July 2007 to May 2018. Fifty-six patients underwent VA-ECMO for refractory cardiogenic shock with the median age of 39.0 (1.5, 103.5) months were included. Median ECMO duration was 87 h, and the median length of hospital stay was 22 days. Successful ECMO weaning rate was 68%. Thirty-day mortality in this cohort was 39% (22/56), among which the mortality of fulminant myocarditis and postcardiotomy cardiogenic shock (PCS) were 23% (6/26) and 52% (12/23), respectively. Multivariate Cox proportional hazard regression analysis identified prolonged prothrombin time (PT) > 6 s and elevated lactate level 24 h after ECMO initiation were associated with 30-day mortality.
Conclusions: Pediatric VA-ECMO for refractory cardiogenic shock appears to be a satisfactory salvage therapy to various fatal diseases in this retrospective study. Prolonged PT > 6 s and elevated lactate level 24 h were significant predictors of 30-day mortality.
What is Known:
• VA-ECMO is a salvage therapy for refractory cardiogenic shock in pediatrics.
What is New:
• Prothrombin time > 6 s was a significant predictor of 30-day mortality.
• Elevated lactate level 24 h was a significant predictor of 30-day mortality
Literatur
2.
Zurück zum Zitat Loforte A, Marinelli G, Musumeci F, Folesani G, Pilato E, Martin Suarez S, Montalto A, Lilla Della Monica P, Grigioni F, Frascaroli G, Menichetti A, Di Bartolomeo R, Arpesella G (2014) Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors. Artif Organs 38(7):E129–E141. https://doi.org/10.1111/aor.12317 CrossRefPubMed Loforte A, Marinelli G, Musumeci F, Folesani G, Pilato E, Martin Suarez S, Montalto A, Lilla Della Monica P, Grigioni F, Frascaroli G, Menichetti A, Di Bartolomeo R, Arpesella G (2014) Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors. Artif Organs 38(7):E129–E141. https://​doi.​org/​10.​1111/​aor.​12317 CrossRefPubMed
7.
Zurück zum Zitat Aso S, Matsui H, Fushimi K, Yasunaga H (2016) In-hospital mortality and successful weaning from venoarterial extracorporeal membrane oxygenation: analysis of 5,263 patients using a national inpatient database in Japan. Crit Care 20(80). https://doi.org/10.1186/s13054-016-1261-1 Aso S, Matsui H, Fushimi K, Yasunaga H (2016) In-hospital mortality and successful weaning from venoarterial extracorporeal membrane oxygenation: analysis of 5,263 patients using a national inpatient database in Japan. Crit Care 20(80). https://​doi.​org/​10.​1186/​s13054-016-1261-1
11.
13.
21.
Zurück zum Zitat Buijs EA, Houmes RJ, Rizopoulos D, Wildschut ED, Reiss IK, Ince C, Tibboel D (2014) Arterial lactate for predicting mortality in children requiring extracorporeal membrane oxygenation. Minerva Anestesiol 80(12):1282–1293PubMed Buijs EA, Houmes RJ, Rizopoulos D, Wildschut ED, Reiss IK, Ince C, Tibboel D (2014) Arterial lactate for predicting mortality in children requiring extracorporeal membrane oxygenation. Minerva Anestesiol 80(12):1282–1293PubMed
Metadaten
Titel
Outcomes following venoarterial extracorporeal membrane oxygenation in children with refractory cardiogenic disease
verfasst von
Lijun Yang
Lifen Ye
Yong Fan
Wenlong He
Qing Zong
Wenting Zhao
Ru Lin
Publikationsdatum
04.03.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 6/2019
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-019-03352-5

Weitere Artikel der Ausgabe 6/2019

European Journal of Pediatrics 6/2019 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.